Skip to content
CharitiesAidWelfare, Medical Health Aged Care

Leukaemia Foundation joins forces with blood cancer survivor Briony Benjamin to raise awareness of lymphoma

Leukaemia Foundation 3 mins read

On World Lymphoma Awareness Day (September 15), the Leukaemia Foundation is joining forces with Gold Coast author, content creator, motivational speaker and inspiring lymphoma survivor, Briony Benjamin.   

As a national ambassador for the Leukaemia Foundation, Briony is hoping to raise much-needed awareness of lymphoma - the most diagnosed form of blood cancer in Australia – and is encouraging anyone impacted by the disease to reach out to the Leukaemia Foundation for support.   

With over 65,200 Australians currently living with lymphomai, World Lymphoma Awareness Day provides an opportunity for the Leukaemia Foundation to educate people on the signs and symptoms of the disease, which can often be subtle and difficult to recognise.  

Common lymphoma symptoms include painless lumps around the lymph nodes usually in the neck, armpit or groin that may be dismissed as harmless. Other symptoms are night sweats, recurrent infections or fevers, and even itchy skin. 

As someone who was misdiagnosed several times before eventually being told she had lymphoma, Briony believes that because the disease can be difficult to spot, it’s especially important to listen to your body and to act when something doesn’t feel right. 

The Leukaemia Foundation encourages Australians to speak to your GP if you have ongoing symptoms that can’t be explained. The sooner that a blood cancer diagnosis occurs, the greater chance people have of beating the disease. 

Anyone impacted by lymphoma, or any type of blood cancer can contact Australia’s blood cancer support line Monday to Friday via calling 1800 620 420 or visit   


  • Briony is a Gold Coast based storyteller, content creator, motivational speaker and author of the book and journal ‘Life is Tough But So Are You’.  

  • Briony was a healthy and fit 31-year-old before she was diagnosed with stage four Hodgkin lymphoma in 2018, a shock diagnosis which instantly turned her life upside down. 

  • Briony was thrown into life-saving treatment almost immediately including months of grueling chemotherapy where she lost her hair. 

  • After eventually being declared cancer-free, it took Briony a long time to recover physically and emotionally from her blood cancer experience.  

  • She is now a healthy and thriving blood cancer survivor and is pregnant with her first child due in October. 

  • Briony is available for interviews to speak about her own first-hand experience with lymphoma and what she hopes to achieve in collaboration with Leukaemia Foundation on World Lymphoma Awareness Day.  

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at 

Lymphoma – facts and figuresii: 

  • Lymphoma is the most common type of blood cancer in Australia. 

  • In 2023, 7,403 Australians will be diagnosed with lymphoma. This is projected to more than double to reach 17,171 people per year by 2035.  

  • Currently, 65,233 Australians are living with lymphoma.  


About us:

About the Leukaemia Foundation: The Leukaemia Foundation has been named Australia's most reputable cancer charity and third most reputable charity overall. We stand with Australia to help cure and conquer blood cancer – with care. Together we are attacking every blood cancer, from every direction, in every way we can. We stand beside every Australian to be their voice and their someone-to-turn to, fighting to get them access to the best care. We also accelerate research that is delivering rapid advancements in blood cancer diagnosis and treatments. Plus, we provide services and support that empower people living with any blood cancer to live well after diagnosis. You can learn more about the Leukaemia Foundation and blood cancer at 

Contact details:

Please contact the Leukaemia Foundation media team to interview Briony Benjamin, and/or a Leukaemia Foundation spokesperson at 


More from this category

  • Environment, Medical Health Aged Care
  • 01/12/2023
  • 10:43
West Australian doctors peak bodies

WA doctors and health professionals call for the government to take urgent action on climate change and end fossil fuel expansion to protect health

On the 1st December, just prior to the COP28 Health Day on the 3rd December, representatives of the medical colleges for general practitioners (GPs), emergency doctors, rural and remote doctors, and surgeons, as well as other doctors and health professionals, gather at 8 am on the steps of Parliament House to call on the WA Government take urgent action on climate change and protect the health of Western Australians. Reiterating calls from medical colleges earlier this year in support of ending fossil fuel expansion and climate action, those gathered today ask the WA government to: End expansion of any new…

  • Medical Health Aged Care
  • 01/12/2023
  • 10:12
Australian Dental Industry Association

ADIA congratulates Senators of the Inquiry into the Provision of and Access to Dental Services in Australia

1 December The Australian Dental Industry Association congratulates the Senators of the Senate Select Committee Inquiry into the Provision of and Access to Dental…

  • Contains:
  • Medical Health Aged Care, Research Development
  • 01/12/2023
  • 09:17

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune

Aegros Releases Top-Line Interim Clinical Trial Results of its COVID-19 Hyperimmune Aegros, an Australian clinical-stage biopharmaceutical company leader in the development and manufacture of plasma derived medicinal products (PDMPs), today announced positive top-line interim results from its CHAT clinical trial. Top-line interim results indicate that Aegros’ COVID-19 hyperimmune provides higher levels of antibodies compared to high-titer convalescent plasma. These results are in line with Aegros’ pre-clinical expectations. CHAT compared Aegros’ COVID-19 hyperimmune to COVID-19 convalescent plasma. The hyperimmune was manufactured using Aegros’ patented Haemafrac® process. A hyperimmune is an intravenous immunoglobulin rich in antibodies that can provide passive immunity for…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time your distribute with Medianet. Pay per release or save with a subscription.